NCT06573242 Home-based Cardiac Rehabilitation for People Living With Heart Failure and Their Caregivers- The DK:REACH-HF Pilot Study
| NCT ID | NCT06573242 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Herlev and Gentofte Hospital |
| Condition | Heart Failure |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2024-08-08 |
| Primary Completion | 2026-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 75 participants in total. It began in 2024-08-08 with a primary completion date of 2026-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background: Participation in cardiac rehabilitation (CR) is a strong recommendation of clinical guidelines for the management of heart failure (HF) because it is demonstrated to be a clinically effective and cost-effective intervention. Despite this, Danish data shows the uptake of CR is suboptimal (51%). A major barrier is that the traditional mode of CR provision is centre based. Travelling (time and cost), dislike of group exercise, and inconvenient timings are some key problems to participation. A potential solution is use of home-based programmes as an alternative to traditional CR. A novel home-based programme for patients with HF and their caregivers (REACH-HF), developed in the United Kingdom has achieved improvements in quality of life and proven to be cost effective. The REACH-HF program is translated and adapted into a Danish context (DK: REACH-HF) and is now ready to be tested in a Danish setting. The aim of this project is to improve the access and uptake of CR among HF patients in Denmark, particularly in subgroups of patients who currently do not benefit from center-based CR.
Eligibility Criteria
Inclusion Criteria: * Aged \> 18 years * Confirmed diagnosis of Heart Failure (HF) with reduced Ejection Fraction (HFrEF) (Ejection Fraction (EF) \<45%) * No worsening of HF symptoms within past 2 weeks resulting in hospitalization (to ensure stable patients) * Are deemed suitable for participating in Cardiac Rehabilitation (CR) by the outpatient HF clinic Exclusion Criteria: * Have undertaken CR within the past 12 months * Are unwilling/unable to travel to a rehabilitation center in the municipality or at the hospital * Are unable to understand the study information and/or corporate on giving informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06573242 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06573242 currently recruiting?
Yes, NCT06573242 is actively recruiting participants. Contact the research team at signe.stelling.risom@regionh.dk for enrollment information.
Where is the NCT06573242 trial being conducted?
This trial is being conducted at Herlev, Denmark, Herlev, Denmark.
Who is sponsoring the NCT06573242 clinical trial?
NCT06573242 is sponsored by Herlev and Gentofte Hospital. The trial plans to enroll 75 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.